US Patent

US9127276 — Conjugated antisense compounds and their use

Composition of Matter · Assigned to Isis Pharmaceuticals Inc · Expires 2034-05-01 · 8y remaining

Vulnerability score 17/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects oligomeric compounds with conjugate groups, including those conjugated to N-Acetylgalactosamine.

USPTO Abstract

Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.

Drugs covered by this patent

Patent Metadata

Patent number: US9127276
Jurisdiction: US
Classification: Composition of Matter
Expires: 2034-05-01
Drug substance claim: Yes
Drug product claim: No
Assignee: Isis Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.